Mayo Clinic Center for Regenerative Medicine Co-Hosts World Stem Cell Summit
The World Stem Cell Summit, December 10-12 in Atlanta, unites and educates the global stem cell community. With more than 1,200 attendees from more than 40 countries, the annual World Stem Cell Summit’s interdisciplinary agenda explores disease updates, research directions, cell standardization, regulatory pathways, reimbursements, financing, venture capital and economic development.
Throughout the week, the Mayo Clinic Center for Regenerative Medicine will use social media to connect using the hashtag #WSCS15. At the end of the week, we'll let the tweets, Google+ posts, Flickr photos, Facebook posts and YouTube videos tell the story.
MEDIA CONTACT: Jennifer Schutz, Mayo Clinic Public Affairs, 507-284-5005, email@example.com
The World Stem Cell Summit includes in-depth programming and more than 200 international speakers, including leaders from the Mayo Clinic Center for Regenerative Medicine:
- Atta Behfar, M.D., Ph.D., is director of the Van Cleve Cardiac Regenerative Medicine Program in the Mayo Clinic Center for Regenerative Medicine. Dr. Behfar and colleagues are working on new science and clinical trials in heart disease that harness the reparative capacity of a patient’s own stem cells.
- Clifford Folmes, Ph.D., is a Scholar of the Mayo Clinic Center for Regenerative Medicine. His research focuses on how changes in energy metabolism direct cell fate and stem cell differentiation. Dr. Folmes has consulted for the Center for the Advancement of Science in Space regarding the implementation of stem cell research on the International Space Station.
- Thomas Gonwa, M.D., is deputy director, Translation, in the Mayo Clinic Center for Regenerative Medicine. He oversees translational regenerative medicine infrastructure across all Mayo Clinic campuses, ensuring technological and translational readiness necessary to sustain scientific excellence, practice advancement and fulfillment of institutional and site-specific goals.
- David Lott, M.D., is director of the Head and Neck Transplantation and Regeneration Program at Mayo Clinic. His practice includes voice and swallowing restoration, laryngeal cancer, and laryngotracheal reconstruction. His research lab is dedicated to investigating regenerative techniques for reconstruction of head and neck defects and safely translating this technology to clinical practice.
- Alan Marmorstein, Ph.D., Professor of Ophthalmology, and his colleagues are studying how to regenerate eye tissue, or even whole eyes, using stem cells. This option would make it possible to restore vision in people who have lost it and prevent loss of vision in those at risk.
- Timothy Nelson, M.D., Ph.D., is director of the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS). In the program, Mayo Clinic physicians and researchers are working to launch clinical trials that bring the latest advances in cell therapy to people with HLHS. Additionally, Dr. Nelson oversees the Regenerative Medicine Consult Service at Mayo Clinic, which provides educational information and appropriate referrals to patients who want to learn about regenerative medicine opportunities at Mayo Clinic and elsewhere.
- Zachary Resch, Ph.D., is assistant professor of medicine and program manager for the Center for Regenerative Medicine Biotrust at Mayo Clinic. The Biotrust specializes in the collection, processing, and storage of patient-specific induced pluripotent and mesenchymal stem cell lines for use in regenerative medicine-related activities including diagnostics, therapeutics and modeling.
- Shane Shapiro, M.D., is a consultant in the Department of Orthopedic Surgery at Mayo Clinic and is Assistant Professor of Orthopedic Surgery at Mayo Clinic College of Medicine. A primary focus of his research has been the study of novel regenerative techniques for chronic non-healing bone, joint, muscle, tendon, ligament and skin maladies that are not candidates for conventional surgical management. Dr. Shapiro has research protocols involving adipose derived stem cells to treat arthritis, and recently, completed an FDA IND clinical trial using mesenchymal stem cells to treat osteoarthritic knees.
- Andre Terzic, M.D., Ph.D., is the Michael S. and Mary Sue Shannon Director, Mayo Clinic Center for Regenerative Medicine and Marriott Family Professor in Cardiovascular Diseases Research. Dr. Terzic has pioneered regenerative medicine at Mayo Clinic, and his program capitalizes on emerging technologies to transform therapeutic modalities from palliative measures to cures.
- Anthony Windebank, M.D., a neurologist and cell biologist, is deputy director for discovery in the Mayo Clinic Center for Regenerative Medicine. He is director of the Cellular Neurobiology Laboratory, which focuses on neuroprotection, repair and regeneration after spinal cord and peripheral nerve injury and stem cell applications for amyotrophic lateral sclerosis, or Lou Gehrig’s disease.
- Henry Walker is program manager for the Mayo Clinic Advanced Product Incubator (API), a state of the art manufacturing facility that supports human phase I/II trials for the Center for Regenerative Medicine. The API is designed to accelerate the discovery, translation and application of novel regenerative products with the focus on developing cell-free biologics-based platforms.
- Abba Zubair, M.D., Ph.D., is a consultant in the Department of Laboratory Medicine and Pathology and medical director, Transfusion Medicine and Stem Cell Therapy at Mayo Clinic in Jacksonville, Fla. Dr. Zubair’s research focuses on the use of stem cells for regenerative medicine applications. He recently received an award from NASA (CASIS) that will allow him to use the microgravity environment to grow stem cells that are of sufficient quality and quantity to use in the treatment of patients with stroke.